Cargando…
Immune response scenario and vaccine development for SARS-CoV-2 infection
COVID-19 pandemic has started in December 2019 in China and quickly extended to become a worldwide health and economic emergency issue. It is caused by the novel coronavirus; SARS-CoV-2. COVID-19 patients’ clinical presentations vary from asymptomatic infection or flu like symptoms to serious pneumo...
Autor principal: | Mohammad, Mai H.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846221/ https://www.ncbi.nlm.nih.gov/pubmed/33571745 http://dx.doi.org/10.1016/j.intimp.2021.107439 |
Ejemplares similares
-
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2020) -
The Comparative Superiority of SARS-CoV-2 Antibody Response in Different Immunization Scenarios
por: Kotsiou, Ourania S., et al.
Publicado: (2022) -
Immune responses to SARS-CoV-2 infection and vaccination in children
por: Brodin, Petter
Publicado: (2023) -
Immune Response to SARS-CoV-2 Vaccines
por: Bellamkonda, Navya, et al.
Publicado: (2022) -
The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)